Taking the helm of EFPIA, Viehbacher says R&D and innovation are the keys to rescuing Europe from its economic slump, but more harmonization across the pharmaceutical sector will be needed too.
To read the original article: U.S. Provides Better Incubation Environment For Biotech Than Europe, Says Sanofi’s Viehbacher :: “The Pink Sheet” :: Elsevier Business Intelligence
